文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Mario Guillen
发表
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
P. Gosse, S. Oparil, Pankaj Gupta, 2022, The Lancet.